Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
What are the Potential Benefits for Active and Aging Adults
Gaucher Disease News: Cerezyme Becomes First FDA-Approved Therapy for Type 3 Gaucher Disease New Treatment for Progressive Pulmonary Fibrosis Lung Disease The FDA approved Boehringer Ingelheims Jascayd (nerandomilast) tablets to treat adults with progressive pulmonary fibrosis (PPF)
TB-500 FDAs 2026 assessment defines TB-500 free base as the N-terminally acetylated amino-acid 17 to 23 fragment of thymosin beta-4
Learn how to use your plans prescription drug lists to make decisions about your medication
US$ 29.04
US$ 28.02
US$ 21.40
US$ 25.95
US$ 29.27
